Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
The sudden outbreak of severe acute respiratory syndrome (SARS) in 2002 prompted the establishment of a global scientific network subsuming most of the traditional rivalries in the competitive field of virology. Within months of the SARS outbreak, collaborative work revealed the identity of the disastrous pathogen as SARS-associated coronavirus (SARS-CoV). However, although the rapid identification of the agent represented an important breakthrough, our understanding of the deadly virus remains limited. Detailed biological knowledge is crucial for the development of effective countermeasures, diagnostic tests, vaccines and antiviral drugs against the SARS-CoV. This article reviews the present state of molecular knowledge about SARS-CoV, from the aspects of comparative genomics, molecular biology of viral genes, evolution, and epidemiology, and describes the diagnostic tests and the anti-viral drugs derived so far based on the available molecular information.
Chow
Ken Yan Ching
KY
Department of Zoology, The University of Hong Kong, Hong Kong SAR, China.
Hon
Chung Chau
CC
Hui
Raymond Kin Hi
RK
Wong
Raymond Tsz Yeung
RT
Yip
Chi Wai
CW
Zeng
Fanya
F
Leung
Frederick Chi Ching
FC
D000818:Animals; D015195:Drug Design; D019143:Evolution, Molecular; D006801:Humans; D045473:Severe acute respiratory syndrome-related coronavirus / Q000235:genetics* / Q000276:immunology / Q000302:isolation & purification; D045169:Severe Acute Respiratory Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy / Q000821:virology*; D014765:Viral Vaccines
D014765:Viral Vaccines